Individualized 3D reconstruction of normal tissue dose for patients with long-term follow-up: A step toward understanding dose risk for late toxicity

International Journal of Radiation Oncology Biology Physics

Volumn 84, Issue 4, 2012, Pages

  Ng, Angela ^a   Brock, Kristy K ^a,b   Sharpe, Michael B ^a,b   Moseley, Joanne L ^a   Craig, Tim ^a,b   Hodgson, David C ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTERIZED TOMOGRAPHY; DOSIMETRY; RADIOTHERAPY; RISK PERCEPTION; TISSUE; TOXICITY;

HODGKIN'S LYMPHOMA; IMAGE-PROCESSING SOFTWARE; LONG-TERM FOLLOW-UP; METHODS AND MATERIALS; RADIATION TOXICITY; STRUCTURAL INFORMATION; THREE-DIMENSIONAL RECONSTRUCTION; TREATMENT PARAMETERS;

IMAGE RECONSTRUCTION;

ADULT; ARTICLE; BREAST; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DOSIMETRY; FEMALE; FOLLOW UP; HEART; HISTOGRAM; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMAGE PROCESSING; LUNG; MALE; MEDICAL RECORD REVIEW; ORGANS AT RISK; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION HAZARD; RISK FACTOR; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING; COMPUTER ASSISTED RADIOTHERAPY; MAMMOGRAPHY; MEDIASTINUM TUMOR; METHODOLOGY; MIDDLE AGED; MOVEMENT (PHYSIOLOGY); RADIATION DOSE; RADIATION EXPOSURE; RADIATION RESPONSE; RADIOGRAPHY;

ADULT; BREAST; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HEART; HODGKIN DISEASE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; LUNG; MALE; MAMMOGRAPHY; MEDIASTINAL NEOPLASMS; MIDDLE AGED; MOVEMENT; ORGANS AT RISK; RADIATION DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 84872029397     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.06.026     Document Type: Article

References (23)

1. Ng AK, Bernardo MP, Weller E, et al. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. J Clin Oncol 2002; 20: 2101-2108.
2. Dabaja BS, Ha CS, Thomas DA, et al. The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma. Cancer 2002; 94: 2738-2744.
3. Travis LB, Hill D, Dores GM, et al. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst 2005; 97: 1428-1437.
4. Hodgson DC, Tsang RW, Pintilie M, et al. Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapy. Int J Radiat Oncol Biol Phys 2003; 57: 1374-1381.
5. Ng A, Nguyen TN, Moseley JL, et al. Reconstruction of 3D lung models from 2D planning data sets for Hodgkin's lymphoma patients using combined deformable image registration and navigator channels. Med Phys 2010; 37: 1017-1028.
6. Ng A, Nguyen TN, Moseley JL, et al. Navigator channel adaptation to reconstruct three dimensional heart volumes from two dimensional radiotherapy planning data. BMC Med Phys 2012; 12: 1.
7. Brock KK, Sharpe MB, Dawson LA, et al. Accuracy of finite element model-based multi-organ deformable image registration. Med Phys 2005; 32: 1647-1659.
8. Nguyen TN, Moseley JL, Dawson LA, et al. Adapting liver motion models using a navigator channel technique. Med Phys 2009; 36: 1061-1073.
9. Deasy JO, Blanco AI, Clark VH. CERR: a computational environment for radiotherapy research. Med Phys 2003; 30: 979-985.
10. Billingsley S, Sun A, McKinnon S, et al. A prospective study to evaluate the need for an immobilization device for treating modified mantle fields in lymphoma patients [abstract]. Int J Radiat Oncol Biol Phys 2005; 63(suppl 1):424.
11. Gilbert ES, Stovall M, Gospodarowicz M, et al. Lung cancer after treatment for Hodgkin's disease: focus on radiation effects. Radiat Res 2003; 159: 161-173.
12. Mulrooney DA, Yeazel MW, Kawashima T, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ 2009; 339: b4606.
13. Sachs RK, Brenner DJ. Solid tumor risks after high doses of ionizing radiation. Proc Natl Acad Sci U S A 2005; 102: 13040-13045.
14. McGale P, Darby SC, Hall P, et al. Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiother Oncol 2011; 100: 167-175.
15. Stovall M, Weathers R, Kasper C, et al. Dose reconstruction for therapeutic and diagnostic radiation exposures: use in epidemiological studies. Radiat Res 2006; 166: 141-157.
16. Janjan NA, Zellmer DL. Calculated risk of breast cancer following mantle irradiation determined by measured dose. Cancer Detect Prev 1992; 16: 273-282.
17. Galper SL, Yu JB, Mauch PM, et al. Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation. Blood 2011; 117: 412-418.
18. Aleman BM, Raemaekers JM, TirelliU, et al. Involved-field radiotherapy for advanced Hodgkin's lymphoma. N Engl J Med 2003; 348: 2396-2406.
19. Hodgson DC, Koh ES, Tran TH, et al. Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma. Cancer 2007; 110: 2576-2586.
20. Campbell BA, Hornby C, Cunninghame J, et al. Minimising critical organ irradiation in limited stage Hodgkin lymphoma: a dosimetric study of the benefit of involved node radiotherapy. Ann Oncol 2011; 23: 1259-1266.
21. Girinsky T, van der Maazen R, Specht L, et al. Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines. Radiother Oncol 2006; 79: 270-277.
22. Marks LB, Yorke ED, Jackson A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 2010; 76 (Suppl. 3):10-19.
23. Taylor CW, Nisbet A, McGale P, et al. Cardiac exposures in breast cancer radiotherapy: 1950s-1990s. Int J Radiat Oncol Biol Phys 2007; 69: 1484-1495.